High-Grade Neuroendocrine Carcinoma of the Larynx
Authors:
- 26 November 2015
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 125 (6) , 464-469
Abstract
Objective: To report a single institutional series of high-grade neuroendocrine carcinoma of the larynx (NCL), a very rare yet aggressive tumor. To review the management of NCL, including discussion of clinical behavior, treatment outcome, and prognosis. Method: A retrospective chart review of high-grade laryngeal neuroendocrine carcinomas at a single institution, including small- and large-cell neuroendocrine carcinomas. A total of 8 patients with high-grade NCL treated at our institution from 1992 to 2014 were identified. Results: The median age at diagnosis was 65.5 years (range, 43-80). Five patients were male. Two patients had a known smoking history. Primary tumor location was supraglottic in 7 patients and glottic in 1 patient. Primary treatment consisted of surgery alone (3 patients), radiotherapy alone (1 patient), combination of chemotherapy and radiotherapy (1 patient), and surgery followed by postoperative chemoradiotherapy (3 patients). Locoregional recurrence followed by distant metastasis occurred in 6 patients. Median overall survival was 44.0 months (95% CI, 3-62.0). Conclusion: High-grade NCL is a rare diagnosis. Compared to well- and moderately differentiated NCL, high-grade NCL has a far more aggressive clinical course and associated with a worse prognosis. To our knowledge, this is the largest series of patients with high-grade NCL treated at a single institution. Prompt diagnosis and multimodality therapy including elective neck dissection may improve survival.Keywords
This publication has 8 references indexed in Scilit:
- Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported casesHead & Neck, 2014
- Large cell neuroendocrine carcinoma of the head and neck: a distinct clinicopathologic entityEuropean Archives of Oto-Rhino-Laryngology, 2014
- Neuroendocrine Neoplasms of the Head and Neck: Some Suggestions for the New WHO Classification of Head and Neck TumorsHead and Neck Pathology, 2014
- Mucosal large cell neuroendocrine carcinoma of the head and neck regions in Japanese patients: a distinct clinicopathological entityJournal of Clinical Pathology, 2012
- Head and Neck Large Cell Neuroendocrine Carcinoma Should Be Separated From Atypical Carcinoid On the Basis of Different Clinical Features, Overall Survival, and PathogenesisAmerican Journal of Surgical Pathology, 2012
- The evolving management of laryngeal neuroendocrine carcinomasEuropean Archives of Oto-Rhino-Laryngology, 2011
- Terminology and classification of neuroendocrine neoplasms of the larynxThe Laryngoscope, 2011
- Large Cell Neuroendocrine Carcinoma of the Larynx: Definition of an EntityHead and Neck Pathology, 2010